Ora

What is the Decay of Indium 111?

Published in Radioactive Decay 4 mins read

Indium-111 (In-111) undergoes radioactive decay primarily through electron capture, transforming into Cadmium-111 (Cd-111) with a physical half-life of 67.2 hours (2.8 days). This specific decay mode and half-life make Indium-111 a valuable radioisotope in various diagnostic applications, particularly in nuclear medicine.

Understanding Electron Capture

Electron capture is a fundamental mode of radioactive decay that occurs when the nucleus of an atom absorbs one of its own orbiting electrons, typically from the K or L shell. This process is distinct from beta-minus or beta-plus decay.

Here's what happens during Indium-111's electron capture:

  • Proton to Neutron Conversion: An electron from an inner atomic shell is captured by a proton within the nucleus. This causes the proton to transform into a neutron.
  • Atomic Number Change: Since a proton is lost, the atomic number of the atom decreases by one, while the atomic mass number remains the same. Indium (In) has an atomic number of 49. When it undergoes electron capture, it transforms into an element with an atomic number of 48, which is Cadmium (Cd). Thus, Indium-111 becomes Cadmium-111.
  • Neutrino Emission: A neutrino is emitted during this process, carrying away some energy.
  • X-ray and Gamma Emission: The daughter nucleus (Cadmium-111) is typically left in an excited state. As it de-excites to a more stable energy level, it emits characteristic X-rays and gamma rays. For Indium-111, these include principal gamma emissions at 171 keV and 245 keV, which are crucial for medical imaging.

You can learn more about this process by visiting the Wikipedia page on Electron Capture.

The Significance of its Half-Life

The physical half-life of 67.2 hours (2.8 days) is a critical characteristic of Indium-111. A half-life is the time required for half of the radioactive atoms in a sample to decay.

  • Optimal for Medical Use: This specific half-life is considered ideal for many diagnostic procedures in nuclear medicine. It's long enough to allow for the preparation of radiopharmaceuticals, their administration to a patient, and subsequent imaging over a period of hours to days, while being short enough to minimize the patient's long-term radiation exposure.
  • Decay Rate: After approximately 2.8 days, half of the original Indium-111 will have decayed into stable Cadmium-111. After another 2.8 days, half of the remaining Indium-111 will decay, and so on.

For more details, see the Wikipedia article on Half-life.

Key Characteristics of Indium-111 Decay

The following table summarizes the essential aspects of Indium-111 decay:

Characteristic Description
Decay Mode Electron Capture (EC)
Daughter Nucleus Cadmium-111 (Cd-111)
Physical Half-Life 67.2 hours (approximately 2.8 days)
Primary Emissions Gamma rays (171 keV and 245 keV, due to de-excitation of daughter nucleus), characteristic X-rays, Auger electrons, and neutrinos.
Clinical Relevance The emitted gamma rays are detectable by specialized imaging equipment like Single-Photon Emission Computed Tomography (SPECT) cameras, making In-111 suitable for various diagnostic studies.

Applications in Nuclear Medicine

Due to its specific decay characteristics, particularly its suitable half-life and gamma emissions, Indium-111 is widely used as a radiotracer in nuclear medicine. It is often conjugated with biological molecules to target specific tissues or processes within the body.

Common applications include:

  • Infection and Inflammation Imaging: Indium-111 is frequently used to label white blood cells (leukocytes) in vitro. These labeled cells are then re-injected into the patient, allowing clinicians to track their migration to sites of infection or inflammation within the body using SPECT imaging.
  • Tumor Localization: Certain radiopharmaceuticals labeled with Indium-111 are used to localize specific types of tumors, especially neuroendocrine tumors.
  • Cerebrospinal Fluid (CSF) Flow Studies: Indium-111-DTPA can be injected into the CSF to evaluate its flow dynamics, aiding in the diagnosis of conditions like normal pressure hydrocephalus.
  • Sentinel Lymph Node Mapping: In some cases, it's used to identify sentinel lymph nodes in certain cancers.

These applications highlight how the precise decay characteristics of Indium-111 are harnessed for critical diagnostic insights, offering a non-invasive way to visualize physiological functions and pathology within the human body.